Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Is this patent for a thrid compound or a fourth that is just coming into the forefront?
2dada
You ready to be subpoenaed to testify before Congress? You know you are the reason for this right? Just kidding.
Remember insider trading is legal for those in Congress therefore it is highly likely he shorted this stock before tweeting or His friends in Congress were aware and did the shorting.
The stock market is near all time highs so the economy must be doing well. The private Federal Reserve Bank is printing money for their proxy banks to shore up The markets. Wonder what happens when the world's privately own Federal Reserve Banks own the world corporations?. I wonder how much of ARIAD is owned by the Federal Reserve Bank proxies and how much of this run up is proxy buying?. I ready don't want to consider the end game.
Remember trading rules and rules for shorting in particular only apply to the individual retail trader.
Well written BR, you have a flair for words.
Will we be seeing a half billion shares out for a billion dollar company?
I really don't agree that Paris is required to be the detail man for specific scientific questions. He has others he can hand those questions off too if needed. Many times Harvey did this himself and this has been part of ARIADs problem as you have so well stated in the past. Harvey's arrogance and hubris has gotten ARIAD into more trouble with the investment community and the FDA than his detailed knowledge.
Sounds like just the person ARIAD needs as someone who can take drugs out of the garbage and make them help people.. Maybe he does not know how to combine sequences if that is what you mean, but it sounds like he knows how to manage results. This is something ARIAD has been failing at for years.
Based on a Wiki search of the German Merk company for the company itself your statement is factually false.
Merck KGaA
"The focus of Merck's current pharmaceutical R&D is on oncology and cardio-metabolic care."
Maybe he had nothing to do with this part of that company? That would be strange if so.
They had to have lost a lot of good people over the last two years. This company is unstable workplace at this time. The Science therefore would not be what it was at one time, today.
2 billion is near 10 a share, better than 6 something I guess.
Dilution coming....this drawdown appears to be pricing dilution into the share price. Nothing else supports a lower price at this time.
This may be optimistic in five years of independent. I have had one other stock like this that became worthless due to share value dilution. This is a distinct possibility.
With HBs continued leadership we would see that company slowly sold in pieces at essentiaaly the current price. Much like what we have seen over last last 18 months and this is why Denner is going to sell soon for a slighly higher value.
In today's FDA it is not about the law as much as it is about the politics, maybe more so than in the past.
HB's issue has never been the lab but his management of the lab's results.
We need to realize that H.B. Is and has been selling Ariad all along, just a piece at a time for little more than status quo. Denner would most likely have sold the whole Company for a multiple of status quo. Each piece sold is just a little less Company for the money originally invested. This is effectively deflation of corporate value directed by Harvey.
Except that we still have a management that can't seem to learn from their mistakes.
Quote
Common stock to be outstanding after this offering
24,782,240 shares
I think this coming week would be a good time for a new molecule announcement...but it is a holiday week so after the new year my be best. The price in the holiday weeks will probably coast generally down as the hedges will want to play some more before the momentum of this last announcement and the next takes the wind out of them. Another but..not sure after seeing this last month if it is possible for the hedge strength can be mitigated.. ..the stocks velocity lately has been astounding...still keeping my shares long for a long time now..
How much proprietary info would be necessary to partner anything? This may be a big issue to any partnership arrangement.
Excellent post and I am in agreement..
The difference is you expect everyone to live and Rachel believes lots will not make and therefore no continuing prescriptions. It all depends on what assumptions you make about survival.
What more could he want...
How about a Nobel prize in medicine if he can show he has the "pattern" to produce molecules that target specific diseases on demand.
If he sold the "pattern" he would probably loose that to some other entity.
Yes, a long time ago.
Hello All,
I have been in Ariad for over 10 years. I am not a trader but someone who put a little extra into a very speculative stock only to see is languish for a long time. Now to see it start to flourish is something to watch. Another three years and this may mature into a real drug company.
Success to long holders....i.e., suckers such as I.